MedPharm Opens Manufacturing Facility for Topical and Transdermal Drug Products
MedPharm’s new facility for process development and small-scale manufacturing is in North Carolina, near its existing R&D center.
MedPharm is opening a new location in Raleigh-Durham, NC, that will expand its contract development and manufacturing organization services in topical and transdermal delivery. The new facility will double the company’s existing footprint and will support process development and clinical and small-scale commercial manufacturing for semi-solid and liquid pharmaceutical products. The new site is located near MedPharm’s current Center of Excellence for topical and transdermal development and adds US good manufacturing practice (GMP) manufacturing.
“MedPharm’s investment in this facility is a clear demonstration of our continued commitment to a global vision by expanding client services downstream into commercial manufacturing,” said Eugene Ciolfi, MedPharm’s president and CEO, in the June 2, 2021 press release.
Source: MedPharm
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
